NC
ORGO icon

nVerses Capital’s Organogenesis Holdings ORGO Stock Holding History

nVerses Capital’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,700
Closed -$16K – 1294
2024
Q2 		$16K Buy
+5,700
New +$15.3K 0.01% 837

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

nVerses Capital's ORGO Position: Q3 2024 in Review

nVerses Capital sold out of Organogenesis Holdings (ORGO) in Q3 2024, closing a stake of 5,700 shares — an estimated $16K sold.

nVerses Capital first reported a position in ORGO in Q2 2024 and held it in 1 quarter. The position peaked at $16K in Q2 2024. 112 funds tracked by Wall St. Rank hold ORGO as of Q3 2024.

  • nVerses Capital reported no remaining Organogenesis Holdings position as of Q3 2024 after selling out during the quarter.
  • nVerses Capital sold 5,700 Organogenesis Holdings shares in Q3 2024, an estimated $16K.
  • nVerses Capital first reported a position in Organogenesis Holdings in Q2 2024 and held it in 1 quarter.
  • nVerses Capital's Organogenesis Holdings position peaked at $16K in Q2 2024.
  • 112 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.